AR002956A1 - Proteinas utiles para el tratamiento de la obesidad y de trastornos relacionados con ella, proceso para obtenerlas y composiciones farmaceuticasque las contienen. - Google Patents
Proteinas utiles para el tratamiento de la obesidad y de trastornos relacionados con ella, proceso para obtenerlas y composiciones farmaceuticasque las contienen.Info
- Publication number
- AR002956A1 AR002956A1 ARP960101202A AR10120296A AR002956A1 AR 002956 A1 AR002956 A1 AR 002956A1 AR P960101202 A ARP960101202 A AR P960101202A AR 10120296 A AR10120296 A AR 10120296A AR 002956 A1 AR002956 A1 AR 002956A1
- Authority
- AR
- Argentina
- Prior art keywords
- obesity
- contain
- treatment
- pharmaceutical compositions
- related disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se describen proteínas anti-obesidad que regulan la formación de tejido adiposo, de forma tal que dichos agentes permiten al paciente superar laobesidad. Se trata de proteínas que responden a la secuencia (SEQ ID NO:8)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38104895A | 1995-01-31 | 1995-01-31 | |
| US38363895A | 1995-02-06 | 1995-02-06 | |
| US45095P | 1995-06-22 | 1995-06-22 | |
| US216195P | 1995-08-11 | 1995-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR002956A1 true AR002956A1 (es) | 1998-05-27 |
Family
ID=27484996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960101202A AR002956A1 (es) | 1995-01-31 | 1996-01-30 | Proteinas utiles para el tratamiento de la obesidad y de trastornos relacionados con ella, proceso para obtenerlas y composiciones farmaceuticasque las contienen. |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPH10513451A (es) |
| KR (1) | KR19980701798A (es) |
| AR (1) | AR002956A1 (es) |
| AU (1) | AU703316B2 (es) |
| BR (1) | BR9606999A (es) |
| CA (1) | CA2211784A1 (es) |
| CO (1) | CO4480035A1 (es) |
| CZ (1) | CZ240497A3 (es) |
| FI (1) | FI973162A (es) |
| NO (1) | NO973515L (es) |
| NZ (1) | NZ301589A (es) |
| PE (1) | PE15197A1 (es) |
| PL (1) | PL321702A1 (es) |
| TR (1) | TR199600085A2 (es) |
| YU (1) | YU5296A (es) |
-
1996
- 1996-01-29 CZ CZ972404A patent/CZ240497A3/cs unknown
- 1996-01-29 CA CA002211784A patent/CA2211784A1/en not_active Abandoned
- 1996-01-29 PL PL96321702A patent/PL321702A1/xx unknown
- 1996-01-29 KR KR1019970705195A patent/KR19980701798A/ko not_active Application Discontinuation
- 1996-01-29 YU YU5296A patent/YU5296A/sh unknown
- 1996-01-29 NZ NZ301589A patent/NZ301589A/xx unknown
- 1996-01-29 BR BR9606999A patent/BR9606999A/pt not_active Application Discontinuation
- 1996-01-29 CO CO96003533A patent/CO4480035A1/es unknown
- 1996-01-29 AU AU47052/96A patent/AU703316B2/en not_active Withdrawn - After Issue
- 1996-01-29 JP JP8523612A patent/JPH10513451A/ja active Pending
- 1996-01-30 AR ARP960101202A patent/AR002956A1/es unknown
- 1996-01-30 PE PE1996000072A patent/PE15197A1/es not_active Application Discontinuation
- 1996-01-31 TR TR96/00085A patent/TR199600085A2/xx unknown
-
1997
- 1997-07-30 NO NO973515A patent/NO973515L/no not_active Application Discontinuation
- 1997-07-30 FI FI973162A patent/FI973162A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ240497A3 (cs) | 1998-01-14 |
| AU703316B2 (en) | 1999-03-25 |
| CO4480035A1 (es) | 1997-07-09 |
| KR19980701798A (ko) | 1998-06-25 |
| JPH10513451A (ja) | 1998-12-22 |
| PL321702A1 (en) | 1997-12-22 |
| NZ301589A (en) | 1999-02-25 |
| BR9606999A (pt) | 1997-10-28 |
| NO973515D0 (no) | 1997-07-30 |
| TR199600085A2 (tr) | 1996-08-21 |
| PE15197A1 (es) | 1997-05-22 |
| CA2211784A1 (en) | 1996-08-08 |
| FI973162A (fi) | 1997-09-30 |
| NO973515L (no) | 1997-09-29 |
| FI973162A0 (fi) | 1997-07-30 |
| AU4705296A (en) | 1996-08-21 |
| YU5296A (sh) | 1998-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1043543A1 (en) | Modified factor VIII. | |
| ATE299710T1 (de) | Methoden zur behandlung von muskelerkrankungen und muskelstörungen | |
| IL151371A0 (en) | Modified porcine factor viii and pharmaceutical compositions containing the same | |
| ES2113635T3 (es) | Aplicacion del riluzole en el tratamiento de lesiones neurologicas relacionadas con traumatismos. | |
| NO20092860L (no) | 2, 6 dioksopiperidin samt farmasoytiske preparater som inneholder disse | |
| ES2114616T5 (es) | Acidos dicarboxilicos alifaticos insaturados. | |
| IL113941A (en) | Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them | |
| PT758241E (pt) | Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses | |
| DE69410254T2 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
| ATE171873T1 (de) | Antiglucocorticoidsteroide zur behandlung von angststörungen | |
| DE69821793D1 (de) | Neuronale verwendungen des bmp-11 | |
| AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
| HUT64565A (en) | Method for producing compounds and preparatives inhibiting resorption of bones | |
| AR002956A1 (es) | Proteinas utiles para el tratamiento de la obesidad y de trastornos relacionados con ella, proceso para obtenerlas y composiciones farmaceuticasque las contienen. | |
| DE69929683D1 (de) | Antisense modulierung von lfa-3 | |
| ATE194076T1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
| DE69521200D1 (de) | Formulierung von energie | |
| ES2097368T3 (es) | Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres. | |
| EE9900464A (et) | Kõhre maatriksi oligomeerse valgu kasutamine reumatoidartriidi raviks | |
| PT817786E (pt) | Acidos tetronicos substituidos uteis para o tratamento do vih e de outros retrovirus | |
| MX9800686A (es) | Nueva proteina hmw humana mp52s. | |
| KR920700224A (ko) | 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제 | |
| ATE312611T1 (de) | Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen | |
| PL322847A1 (en) | Condensed b-carbolins | |
| GEP19991605B (en) | Inhibitor, Its Obtaining and Use |